Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Net Cash Flow (2014 - 2026)

Ocugen's (OCGN) quarterly Net Cash Flow came in at $13.2 million in Q1 2026, up 163.68% YoY from $5.0 million in Q1 2025, and up 194.21% on a QoQ basis from -$14.0 million in Q4 2025.

Analysis

Ocugen (OCGN) Net Cash Flow (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Net Cash Flow data on file, last reported at $13.2 million in Q1 2026.

  • Quarterly Net Cash Flow rose 163.68% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.1 million (down 151.7% YoY) and the FY2025 annual result came in at -$39.9 million, down 306.65% from the prior year.
  • Net Cash Flow advanced to $13.2 million in Q1 2026, from -$14.0 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $34.8 million in Q1 2022 to a low of -$24.0 million in Q4 2022.
  • A 5-year average of -$3.7 million and a median of -$10.8 million in 2025 frame the typical range for Net Cash Flow.
  • The widest YoY moves for Net Cash Flow: up 241.31% in 2024, down 547.18% in 2024.
  • Tracing OCGN's Net Cash Flow over 5 years: stood at -$24.0 million in 2022, then soared by 41.72% to -$14.0 million in 2023, then jumped by 241.31% to $19.8 million in 2024, then plunged by 170.69% to -$14.0 million in 2025, then soared by 194.21% to $13.2 million in 2026.
  • The last three Net Cash Flow figures came in at $13.2 million (Q1 2026), -$14.0 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Ocugen 458.91 Mn 358.81 Mn - 68.15 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.15 Mn
Mar 31, 2026 13.18 Mn
Dec 31, 2025 -13.99 Mn
Sep 30, 2025 5.51 Mn
Jun 30, 2025 -10.76 Mn
Mar 31, 2025 -20.70 Mn
Dec 31, 2024 19.80 Mn
Sep 30, 2024 23.01 Mn
Jun 30, 2024 -10.38 Mn
Mar 31, 2024 -13.09 Mn
Dec 31, 2023 -14.01 Mn
Sep 30, 2023 -17.11 Mn
Jun 30, 2023 2.32 Mn
Mar 31, 2023 -9.30 Mn
Dec 31, 2022 -24.03 Mn
Sep 30, 2022 -13.42 Mn
Jun 30, 2022 -14.93 Mn
Mar 31, 2022 34.81 Mn
Dec 31, 2021 -12.39 Mn
Sep 30, 2021 -8.29 Mn